Three-drug attack on deadly lung pressure disease
NCT ID NCT07266519
Summary
This study is testing whether starting treatment with three different medications right away is better for people newly diagnosed with pulmonary arterial hypertension (PAH), a serious condition that causes high blood pressure in the lungs. It will involve 25 participants who will take the three-drug combination for 24 weeks. The main goal is to see how much this treatment reduces the resistance in the blood vessels of the lungs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION (PAH) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.